A Promising Target to Treat Myotonic Dystrophy Type 1 (3 of 3) (IMAGE)

American Association for the Advancement of Science (AAAS)

A Promising Target to Treat Myotonic Dystrophy Type 1 (3 of 3)

Caption

Nuclear foci in untreated cells. This material relates to a paper that appeared in the Apr. 29, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by A. Ketley at Queen's Medical Centre in Nottingham, UK; and colleagues was titled, "CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model."

Credit

[Credit: Dr. Ami Ketley]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.